Prostatype Genomics appoints Professor Gerald Andriole as Chief Medical Officer
SOLNA, Sweden, May 5, 2023 /PRNewswire/ -- Prostatype Genomics AB announced today that Professor Gerald Andriole has been appointed as global Chief Medical Officer at Prostatype Genomics.
- SOLNA, Sweden, May 5, 2023 /PRNewswire/ -- Prostatype Genomics AB announced today that Professor Gerald Andriole has been appointed as global Chief Medical Officer at Prostatype Genomics.
- With more than 35 years in urology, Professor Andriole brings a wealth of experience and expertise to Prostatype Genomics as the company works towards commercializing the Prostatype® test in the United States and globally.
- Professor Andriole received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania.
- Fredrik Persson CEO of Prostatype Genomics says "We are honored that Professor Andriole has decided to join Prostatype Genomics.